feed,title,long_url,short_url
Benzinga,Verve Therapeutics Posts Updated Preclinical Data For Gene-Editing Therapy In Cardiovascular Disease,https://benzinga.com/general/biotech/22/08/28584823/verve-therapeutics-posts-updated-preclinical-data-for-gene-editing-therapy-in-cardiovascular-dise,https://bit.ly/3PHKXbc
